Baguio, Chaniel B.

HRN: 27-98-89  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2025
OXACILLIN 500MG (VIAL)
10/25/2025
11/01/2025
IV
200mg
Q6h
IMPETIGO
Checking Final Appropriateness 
10/25/2025
MUPIROCIN 2%, 15G (TUBE)
10/25/2025
11/01/2025
TOPICAL
AS NEEDED
BID
IMPETIGO
Checking Final Appropriateness 
10/25/2025
ACICLOVIR 400MG (TAB)
10/25/2025
10/30/2025
PO
160mg/pptab
Q6
T/c Severe Varicella With Superimposed Bacteria R/o Aciclovir
Checking Final Appropriateness 
10/25/2025
CEFTRIAXONE 1G (VIAL)
10/25/2025
11/01/2025
IV
400mg
Q12
T/c Severe Varicella With Superimposed Bacteria R/o Aciclovir
Checking Final Appropriateness 
10/30/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/30/2025
11/05/2025
IV
100mg
Q8
T/C Varicella With Superimposed Bacteria
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: